Rani Therapeutics Holdings, Inc. (RANI) SEC filings

Name: Rani Therapeutics Holdings, Inc. (RANI) SEC filings: latest 10-K, 10-Q, 8-K and insider forms
Creator: Agent Exchange
License: https://www.sec.gov/privacy#dissemination

CIK 0001856725 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in CA · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

	FY2025	FY2024	FY2023	FY2022
Revenue (USD)	1.6 M	0		0
Net income (USD)	-29.7 M	-34.0 M	-30.6 M
Diluted EPS (USD/shares)	-0.45	-1.33	-1.28

Latest filings

Filed	Form	Description	Period
2026-09-29	4	4	2026-09-27
2026-09-29	4	4	2026-09-27
2026-08-14	SCHEDULE 13G/A	SCHEDULE 13G/A
2026-08-13	10-Q	10-Q	2026-06-30
2026-08-13	8-K	8-K items 2.02,9.01	2026-08-13
2026-08-04	4	4	2026-08-03
2026-08-04	3	3	2026-08-01
2026-08-04	8-K	8-K items 5.02	2026-08-01
2026-07-31	SCHEDULE 13G/A	SCHEDULE 13G/A
2026-07-23	4	4	2026-07-21
2026-07-21	4	4	2026-03-27
2026-07-21	4	4	2026-07-17
2026-07-21	4	4	2024-12-27
2026-07-21	4	4	2026-07-17
2026-07-15	S-8	S-8
2026-07-08	3	3	2026-06-29
2026-06-30	8-K	8-K items 5.02,9.01	2026-06-24
2026-06-05	4	4	2026-06-03
2026-06-05	4	4	2026-06-03
2026-06-05	4	4	2026-06-03
2026-06-01	4	4	2026-05-28
2026-06-01	4	4	2026-05-28
2026-06-01	4	4	2026-05-28
2026-06-01	4	4	2026-05-28
2026-06-01	4	4	2026-05-28

Forms on file (last 1,000): 4 162, 8-K 63, 3 20, 10-Q 16, 3/A 11, CORRESP 10, 424B5 9, SCHEDULE 13G 8. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=RANI (0.002 USD), /gw/filings/filings?ticker=RANI&form=8-K, /gw/filings/facts?ticker=RANI&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange